Trials / Recruiting
RecruitingNCT07207564
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,500 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Female
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-interventional study |
Timeline
- Start date
- 2025-08-28
- Primary completion
- 2030-06-30
- Completion
- 2030-06-30
- First posted
- 2025-10-06
- Last updated
- 2026-03-13
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07207564. Inclusion in this directory is not an endorsement.